New findings from an RV144 follow-on study published today in Science Translational Medicine provide key insights into the role that host-genetics played in protecting against HIV-1 infection during the landmark “Thai Study.”
Dr. Ananworanich will oversee adult HIV therapeutic trials as part of the newly-funded MHRP Clinical Trials Unit under the AIDS Clinical Trials Group (ACTG).
